Lucila Kerbauy: Precision Medicine in AML and CAR Cells
Lucila Kerbauy, Head of Cell Therapy Center at Einstein Hospital Israelita, reposted from Larissa Zanetti, on LinkedIn:
“I’m very happy and proud to share another publication from our group on CAR-T cell therapy for acute myeloid leukemia (AML).
A special thank you to our team and collaborators who make this work possible. Advancing innovative and accessible cell therapies in Brazil and beyond is truly a collective effort.”
Quoting Larissa Zanetti’s post:
“It’s out!
I’m very proud to share our recent publication, “Precision Medicine in AML and CAR Cells: Where Are We?” — a collaborative effort uniting two leading research groups from our institution.
In this work, we explore how precision medicine and CAR-based cellular therapies (CAR-T and CAR-NK) are converging to transform the landscape of acute myeloid leukemia (AML) treatment. The review highlights the critical role of patient-specific approaches, novel target discovery, and next-generation cell engineering in shaping the future of personalized immunotherapy.
I truly believe that as the field of advanced cell therapies continues to expand, the integration of precision medicine principles will become increasingly essential.
A huge thank you to my incredible collaborators and mentors who made this work possible.”
Article: Precision medicine with car cells in acute myeloid leukemia: where are we?
Authors: Larissa C. Zanetti, Victoria Tomaz, Ingrid Ferreira de Souza, Paulo V. Campregher, Nelson Hamerschlak, Lucila N. Kerbauy
Read the full article here.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 9, 2026, 16:40We Are Incredibly Grateful to Our Volunteers – Hemophilia of Georgia
-
Apr 9, 2026, 15:10Christoffer Gebhardt: Can Anticoagulation Improve Outcomes in Melanoma Therapy?
-
Apr 9, 2026, 15:09National Institutes of Health Addresses VTE Research Funding Gap – JTH
-
Apr 9, 2026, 15:08Alice Assinger: Recruiting PhD Students for NET-IT Doctoral Program in Vienna
-
Apr 9, 2026, 15:07Hannah Cohen: A Novel Approach to Post-Stroke Gait Rehabilitation
-
Apr 9, 2026, 15:07Shehab Mohamed: A Single-Center Experience on Stroke Risk in Polycythemia Vera
-
Apr 9, 2026, 15:06Catch the Brand-New Recap of the Phase III OCEANIC-STROKE Trial – ISTH
-
Apr 9, 2026, 15:06Neeraj Jain: Building Capacity for Better Haemoglobinopathy Care in Maharashtra
-
Apr 9, 2026, 15:05Esther Nakkazi: Armenia Leads WHO Resolution to Advance Haemophilia Care Worldwide